Aptargroup

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptargroup and other ETFs, options, and stocks.

About ATR

AptarGroup, Inc. engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage. 

CEO
Stephan B. Tanda
CEOStephan B. Tanda
Employees
13,500
Employees13,500
Headquarters
Crystal Lake, Illinois
HeadquartersCrystal Lake, Illinois
Founded
1940
Founded1940
Employees
13,500
Employees13,500

ATR Key Statistics

Market cap
8.27B
Market cap8.27B
Price-Earnings ratio
20.19
Price-Earnings ratio20.19
Dividend yield
1.45%
Dividend yield1.45%
Average volume
410.98K
Average volume410.98K
High today
$126.11
High today$126.11
Low today
$123.87
Low today$123.87
Open price
$124.43
Open price$124.43
Volume
342.28K
Volume342.28K
52 Week high
$164.28
52 Week high$164.28
52 Week low
$103.23
52 Week low$103.23

Stock Snapshot

Aptargroup(ATR) stock is priced at $126.00, giving the company a market capitalization of 8.27B. It carries a P/E multiple of 20.19 and pays a dividend yield of 1.5%.

As of 2026-01-24, Aptargroup(ATR) stock has fluctuated between $123.87 and $126.11. The current price stands at $126.00, placing the stock +1.7% above today's low and -0.1% off the high.

The Aptargroup(ATR)'s current trading volume is 342.28K, compared to an average daily volume of 410.98K.

In the last year, Aptargroup(ATR) shares hit a 52-week high of $164.28 and a 52-week low of $103.23.

In the last year, Aptargroup(ATR) shares hit a 52-week high of $164.28 and a 52-week low of $103.23.

ATR News

Simply Wall St 5d
Assessing AptarGroup Valuation After New Nasal Vaccine And Eye Care Technology Developments

AptarGroup (ATR) is back in focus after its LuerVax and Spray Divider nasal devices were selected for CastleVax’s Phase II intranasal COVID-19 vaccine trial, al...

Assessing AptarGroup Valuation After New Nasal Vaccine And Eye Care Technology Developments
Simply Wall St 6d
Is Aptar's Nasal Vaccine Role And Eye Care Push Altering The Investment Case For AptarGroup?

In January 2026, AptarGroup announced that its LuerVax and Spray Divider nasal vaccine delivery systems are being used in CastleVax’s Phase II trial of the CVAX...

Is Aptar's Nasal Vaccine Role And Eye Care Push Altering The Investment Case For AptarGroup?

Analyst ratings

70%

of 10 ratings
Buy
70%
Hold
30%
Sell
0%

People also own

Based on the portfolios of people who own ATR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.